Authors:
VAVASOUR IM
WHITTALL KP
MACKAY AL
LI DKB
VOROBEYCHIK G
PATY DW
Citation: Im. Vavasour et al., A COMPARISON BETWEEN MAGNETIZATION-TRANSFER RATIOS AND MYELIN WATER PERCENTAGES IN NORMALS AND MULTIPLE-SCLEROSIS PATIENTS, Magnetic resonance in medicine, 40(5), 1998, pp. 763-768
Citation: Gj. Zhao et al., ACTIVE MULTIPLE-SCLEROSIS LESIONS OCCUR IN DIRTY-APPEARING WHITE-MATTER AS DETECTED BY SERIAL MAGNETIC-RESONANCE-IMAGING, Annals of neurology, 44(3), 1998, pp. 95-95
Authors:
KASTRUKOFF LF
MORGAN NG
ZECCHINI D
PATY DW
Citation: Lf. Kastrukoff et al., A ROLE FOR NATURAL-KILLER-CELLS IN THE IMMUNOPATHOGENESIS OF MULTIPLE-SCLEROSIS, Annals of neurology, 44(3), 1998, pp. 173-173
Citation: Dw. Paty et Ld. Blumhardt, HIGH-DOSE SUBCUTANEOUS INTERFERON BETA-1A IS EFFICACIOUS IN TRANSITIONAL MULTIPLE-SCLEROSIS, A GROUP AT HIGH-RISK FOR PROGRESSION IN DISABILITY, Annals of neurology, 44(3), 1998, pp. 240-240
Authors:
FILIPPI M
HORSFIELD MA
ADER HJ
BARKHOF F
BRUZZI P
EVANS A
FRANK JA
GROSSMAN RI
MCFARLAND HF
MOLYNEUX P
PATY DW
SIMON J
TOFTS PS
WOLINSKY JS
MILLER DH
Citation: M. Filippi et al., GUIDELINES FOR USING QUANTITATIVE MEASURES OF BRAIN MAGNETIC-RESONANCE-IMAGING ABNORMALITIES IN MONITORING THE TREATMENT OF MULTIPLE-SCLEROSIS, Annals of neurology, 43(4), 1998, pp. 499-506
Authors:
KASTRUKOFF LF
MORGAN NG
ZECCHINI D
WHITE R
PETKAU AJ
SATOH JI
PATY DW
Citation: Lf. Kastrukoff et al., A ROLE FOR NATURAL-KILLER-CELLS IN THE IMMUNOPATHOGENESIS OF MULTIPLE-SCLEROSIS, Journal of neuroimmunology, 86(2), 1998, pp. 123-133
Authors:
LI DKB
ZHAO GJ
HYDE R
DUPONT F
ABDULAHAD A
CHENG Y
WANG XY
PATY DW
Citation: Dkb. Li et al., COMPARISON OF THE THERAPEUTIC EFFECT OF INTERFERON BETA-1A (REBIF) ONDIFFERENT LEVELS OF BASE-LINE MRI ACTIVITY, Neurology, 50(4), 1998, pp. 17001-17001
Authors:
PATY DW
ZHAO GJ
HYDE R
DUPONT F
ABDULAHAD A
CHENG Y
WANG XY
LI DKB
Citation: Dw. Paty et al., COMPARISON BETWEEN PROTON DENSITY T2 GADOLINIUM-ENHANCED T1 MRI IN DEMONSTRATING A TREATMENT EFFECT AND DOSE DIFFERENCE IN PRISMS TRIAL OF INTERFERON BETA-1A (REBIF), Neurology, 50(4), 1998, pp. 17002-17002
Authors:
ZHAO GJ
LI DKB
HYDE R
ABDULAHAD A
CHENG Y
WANG XY
PATY DW
Citation: Gj. Zhao et al., RELAPSING-REMITTING MS IS MORE ACTIVE THAN SECONDARY-PROGRESSIVE MS ON GADOLINIUM-ENHANCED MRI, Neurology, 50(4), 1998, pp. 37002-37002
Citation: Dw. Paty et H. Mcfarland, MAGNETIC-RESONANCE TECHNIQUES TO MONITOR THE LONG-TERM EVOLUTION OF MULTIPLE-SCLEROSIS PATHOLOGY AND TO MONITOR DEFINITIVE CLINICAL-TRIALS, Journal of Neurology, Neurosurgery and Psychiatry, 64, 1998, pp. 47-51
Citation: Mk. Hockertz et al., SUSCEPTIBILITY TO RELAPSING-PROGRESSIVE MULTIPLE-SCLEROSIS IS ASSOCIATED WITH INHERITANCE OF GENES LINKED TO THE VARIABLE REGION OF THE TCR-BETA LOCUS - USE OF AFFECTED FAMILY-BASED CONTROLS, American journal of human genetics, 62(2), 1998, pp. 373-385
Authors:
ZHAO GJ
REDEKOP WK
RIDDEHOUGH A
LI DKB
COVER K
WOLINSKY JS
PATY DW
KOOPMANS RA
MIETLOWSKI W
SCHEINBERG LC
TRAUGOTT U
AISEN M
ROBBINS K
HURWITZ BJ
GREENBERG SM
FREDANE LM
HERBSTREITH R
HURWITZ JG
BURK J
MCFARLAND HF
GOODMAN A
MCFARLIN DE
KREBS H
MALONI H
DEBRONSO J
FRANKLIN GM
BURKS JS
NELSON L
WANGAARD C
SEARS S
NATH A
SMITH L
MCGINNIS J
TOURTELLOTE WW
BAUMHEFNER RW
ELLISON G
MEYERS L
SYNDULKO K
NEWTON L
Citation: Gj. Zhao et al., CLINICAL AND MAGNETIC-RESONANCE-IMAGING CHANGES CORRELATE IN A CLINICAL-TRIAL MONITORING CYCLOSPORINE THERAPY FOR MULTIPLE-SCLEROSIS, Journal of neuroimaging, 7(1), 1997, pp. 1-7
Citation: Dw. Paty, FUNDING OF DRUG-TREATMENT OF MULTIPLE-SCLEROSIS SHOULD NOT BE DELAYED, BMJ. British medical journal, 315(7116), 1997, pp. 1160-1161
Authors:
WHITTALL KP
MACKAY AL
GRAEB DA
NUGENT RA
LI DKB
PATY DW
Citation: Kp. Whittall et al., IN-VIVO MEASUREMENT OF T-2 DISTRIBUTIONS AND WATER CONTENTS IN NORMALHUMAN BRAIN, Magnetic resonance in medicine, 37(1), 1997, pp. 34-43
Authors:
CHENG Y
ZHAO GJ
LI DKB
KOOPMANS R
PATY DW
Citation: Y. Cheng et al., MRI LESION ACTIVITY AND ACCUMULATION IN MS PATIENTS WITH NEUTRALIZINGANTIBODIES OF INTERFERON BETA-1B, Neurology, 48(3), 1997, pp. 4072-4072
Citation: D. Li et al., CAN MORPHOLOGICAL-CHANGES IN MRI ACTIVE LESIONS OCCUR PRIOR TO THEIR BLOOD-BRAIN-BARRIER BREAKDOWN IN MS, Neurology, 48(3), 1997, pp. 5084-5084
Citation: Xy. Wang et al., COMPARISON OF MRI LESION DISTRIBUTION BETWEEN RELAPSING-REMITTING ANDSECONDARY PROGRESSIVE MS, Neurology, 48(3), 1997, pp. 5086-5086
Authors:
ZHAO G
LI DKB
KOOPMANS RA
BEDELL L
PATY DW
Citation: G. Zhao et al., CORRELATION OF CLINICAL STATUS WITH MS LESION CHANGES IN UNTREATED PATIENTS - A 5-YEAR STUDY BY YEARLY MRI, Neurology, 48(3), 1997, pp. 55003-55003
Authors:
EBERS GC
KUKAY K
BULMAN DE
SADOVNICK AD
RICE G
ANDERSON C
ARMSTRONG H
COUSIN K
BELL RB
HADER W
PATY DW
HASHIMOTO S
OGER J
DUQUETTE P
WARREN S
GRAY T
OCONNOR P
NATH A
AUTY A
METZ L
FRANCIS G
PAULSETH JE
MURRAY TJ
PRYSEPHILLIPS W
NELSON R
FREEDMAN M
BRUNET D
BOUCHARD JP
HINDS D
RISCH N
Citation: Gc. Ebers et al., A FULL GENOME SEARCH IN MULTIPLE-SCLEROSIS, Nature genetics, 13(4), 1996, pp. 472-476
Citation: Gj. Zhao et al., CORRELATION OF MAGNETIC-RESONANCE-IMAGING LESION ACTIVITY WITH CHANGEOF BURDEN OF DISEASE IN MULTIPLE-SCLEROSIS PATIENTS, Annals of neurology, 40(3), 1996, pp. 251-251
Authors:
MILLER DH
ALBERT PS
BARKHOF F
FRANCIS G
FRANK JA
HODGKINSON S
LUBLIN FD
PATY DW
REINGOLD SC
SIMON J
Citation: Dh. Miller et al., GUIDELINES FOR THE USE OF MAGNETIC-RESONANCE TECHNIQUES IN MONITORINGTHE TREATMENT OF MULTIPLE-SCLEROSIS, Annals of neurology, 39(1), 1996, pp. 6-16